共 30 条
- [1] AnaptysBio, 2022, ROSNILIMAB
- [4] Clinicaltrials.gov, Safety and efficacy of oral etrasimod in adult participants with moderatetosevere alopecia areata [Web page]
- [5] Clinicaltrials.gov, 2022, Phase 2 trial of BNZ1 in patients with moderate to severe alopecia areata [Web page]
- [6] Clinicaltrials.gov, 2022, Study of DAXDILIMAB for the treatment of moderatetosevere alopecia areata [Web page]
- [7] Clinicaltrials.gov, 2022, A study to evaluate the efficacy and safety of rosnilimab (ANB030) in treatment of subjects with moderateto severe alopecia areata (AZURE) [Web page]
- [9] Medical Progress Alopecia Areata [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (16) : 1515 - 1525
- [10] Hirani R, 2023, JAAD INT, V10, P84, DOI 10.1016/j.jdin.2022.12.003